Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Result of placing

26 Nov 2010 13:42

RNS Number : 8882W
Chesnara PLC
26 November 2010
 



Chesnara plc

 

NOT FOR RELEASE PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES

 

Chesnara plc

 

 

Result of Placing raising approximately £26.7 million at a Placing Price of 200 pence per Placing Share

 

Chesnara plc ("Chesnara" or "the Company") is pleased to announce the successful completion of the placing of new ordinary shares and treasury shares announced earlier today (the "Placing").

 

A total of 10,458,877 new ordinary shares of 5 pence each in the Company (the "New Shares") and 2,897,183 ordinary shares of 5 pence each held in treasury (the "Treasury Shares") (together the "Placing Shares") have been placed by Collins Stewart Europe Limited ("Collins Stewart") and Panmure Gordon (UK) Limited ("Panmure Gordon") with institutional investors at a price of 200 pence per Placing Share (the "Placing Price").

 

The gross proceeds of the Placing will be approximately £26.7 million. The New Shares and the Treasury Shares represent approximately 9.99 per cent. and 2.77 per cent. respectively of the issued ordinary share capital (including shares held in treasury) of Chesnara prior to completion of the Placing. The Placing Shares will represent approximately 11.6% per cent. of the enlarged issued share capital (including shares held in treasury) of Chesnara immediately following completion of the Placing.

 

The New Shares will, when issued, be credited as fully paid and will rank equally in all respects with the existing ordinary shares of 5 pence each in the share capital of Chesnara, including the right to receive all dividends and other distributions declared, made or paid after the date of issue of the New Shares. Following completion of the Placing, the enlarged issued share capital of the Company will be 115,047,662 ordinary shares of 5 pence each (including shares held in treasury).

 

As part of the Placing, certain Directors of the Company have agreed to subscribe for Placing Shares. The number of Placing Shares subscribed by each Director and their resultant interest in the enlarged ordinary share capital of the Company is set out below:

 

Director/PDMR

Existing holding of ordinary shares

Number of Placing Shares subscribed for

Total number of ordinary shares following the Placing

% enlarged issued ordinary share capital

Graham Kettleborough

42,600

15,500

58,100

0.05%

Mike Gordon

--

--

--

Frank Hughes

5,163

669

5,832

0.01%

Terry Marris

52,708

5,000

57,708

0.05%

Peter Mason

17,500

2,268

19,768

0.02%

Ken Romney

50,476

20,000

70,476

0.06%

Peter Wright

20,000

50,000

70,000

0.06%

 

Application will be made to the FSA (in its capacity as UK Listing Authority) for the New Shares to be admitted to the Official List maintained by the FSA and to trading by the London Stock Exchange plc on its main market for listed securities (together "Admission").

 

It is expected that Admission will take place and that trading in the Placing Shares will commence at 8.00 a.m. on 1 December 2010. The Placing remains conditional upon, amongst other things, Admission taking place no later than 1 December 2010 (or such later time as may be agreed between the Company, Collins Stewart and Panmure Gordon) and on the placing agreement between the Company, Collins Stewart and Panmure Gordon and dated today's date becoming unconditional and not being terminated prior to Admission.

 

 

 

Enquiries

 

Chesnara plc

Graham Kettleborough, Chief Executive

 

+44 (0) 7799 407519

Collins Stewart - joint bookrunner and joint corporate broker

Adrian Hadden

Tom Hulme

Matt Goode

 

Panmure Gordon - joint bookrunner and joint corporate broker

Hugh Morgan

Tom Nicholson

Giles Stewart

+44 (0) 207 523 8350

 

 

 

 

 

+44 (0) 207 459 3600

 

Cubitt Consulting

Michael Henman

+44 (0) 207 367 5100

Samantha Boston

 

 

Important Information

 

The information contained in this announcement is not for publication or for release or distribution in whole or in part in, into or from the United States, Canada, Japan, South Africa, Australia or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

The Placing Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold or delivered, directly or indirectly, in or into the United States absent registration under the Securities Act, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Placing Shares are being offered and sold outside the United States only in offshore transactions in accordance with Regulation S under the Securities Act. No public offering of the Placing Shares is being made in the United States.

 

This announcement does not constitute an offer to sell or issue or a solicitation of an offer to buy or subscribe for Placing Shares in any jurisdiction including, without limitation, the United States, Canada, Australia, Japan, South Africa or any other jurisdiction in which such offer or solicitation is or may be unlawful.

 

Collins Stewart Europe Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as joint bookrunner and joint corporate broker exclusively for Chesnara plc and is acting for no-one else in connection with the Placing and will not be responsible to anyone other than Chesnara plc for providing the protections afforded to clients of Collins Stewart Europe Limited nor for providing advice in connection with the Placing, or any other matter referred to in this announcement.

 

Panmure Gordon (UK) Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as joint bookrunner and joint corporate broker exclusively for Chesnara plc and for no one else in connection with the Placing and will not be responsible to anyone other than Chesnara plc for providing the protections afforded to clients of Panmure Gordon (UK) Limited or for affording advice in relation to the Placing, or any other matters referred to in this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIEADFKALFEFFF
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.